Acadia Pharmaceuticals



金融业
股票价格
USD
资产
USD 1.33B
现金及等价物
USD 847.02M
销售成本
USD 21.65M
流动资产
USD 1.08B
流动负债
USD 356.58M
债务
USD 56.29M
EBIT
USD 35.76M
EBITDA
USD 35.76M
员工
653
EPS每股收益
USD 0.42
股本和储备
USD 917.27M
销售毛利
USD 256.99M
债务利息支出
USD 0
利息收入
USD 7.24M
贷款资金
USD 0
市值
USD 4.12B
净收入
USD 71.78M
营业费用
USD 242.88M
营业利润
USD 35.76M
普通股股本
USD 168.71M
PE价格收益
USD 13.7
税前利润
USD 44.6M
销售收入
USD 278.6M
销售和管理费用
USD 124.91M
股票
USD 29.1M
贸易债权人
USD 21.75M
应收帐款人
USD 139.44M


Ebitda 更改 日
Acadia Pharmaceuticals USD 35.76M 447K 2025-09
ALKERMES USD 121.55M 4.99M 2025-09
Alnylam Pharmaceuticals USD 381.78M 362.95M 2025-09
Biogen USD 1.01B 456.5M 2025-06
BioMarin Pharmaceutical USD 295.45M 49.49M 2025-06
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Corcept Therapeutics USD 27.14M 23.27M 2025-06
Cytokinetics USD -107.82M 45.51M 2025-06
Eisai JPY 23.48B 14.68B 2025-09
Eli Lilly USD 7.88B 378.1M 2025-09
Incyte USD 581.52M 358.87M 2025-06
J&J USD 9.52B 389M 2025-09
Moderna USD -208M 552M 2025-09
Neurocrine Biosciences USD 246.7M 93.8M 2025-09
Pfizer USD 6.08B 351M 2025-09
Prothena USD -39.53M 12.25M 2025-09
PTC Therapeutics USD -33.11M 1B 2025-06
Sarepta Therapeutics USD 126.42M 416.82M 2025-06
Ultragenyx Pharmaceutical USD -91.34M 35.09M 2025-06
Vertex Pharmaceuticals USD 1.44B 100.4M 2025-09


Acadia Pharmaceuticals - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.